- Home
- MREO vs ITIC Comparison
MREO vs ITIC Comparison
Compare MREO & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- ITIC
- Stock Information
- Founded
- MREO 2015
- ITIC 1972
- Country
- MREO United Kingdom
- ITIC United States
- Employees
- MREO N/A
- ITIC N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- ITIC Specialty Insurers
- Sector
- MREO Health Care
- ITIC Finance
- Exchange
- MREO Nasdaq
- ITIC Nasdaq
- Market Cap
- MREO 438.8M
- ITIC 440.1M
- IPO Year
- MREO N/A
- ITIC N/A
- Fundamental
- Price
- MREO $2.87
- ITIC $215.93
- Analyst Decision
- MREO Strong Buy
- ITIC
- Analyst Count
- MREO 5
- ITIC 0
- Target Price
- MREO $7.60
- ITIC N/A
- AVG Volume (30 Days)
- MREO 1.3M
- ITIC 62.4K
- Earning Date
- MREO 08-12-2025
- ITIC 08-05-2025
- Dividend Yield
- MREO N/A
- ITIC 7.43%
- EPS Growth
- MREO N/A
- ITIC 18.56
- EPS
- MREO N/A
- ITIC 15.69
- Revenue
- MREO N/A
- ITIC $261,197,999.00
- Revenue This Year
- MREO N/A
- ITIC N/A
- Revenue Next Year
- MREO $52.34
- ITIC N/A
- P/E Ratio
- MREO N/A
- ITIC $13.73
- Revenue Growth
- MREO N/A
- ITIC 15.27
- 52 Week Low
- MREO $1.58
- ITIC $174.85
- 52 Week High
- MREO $5.02
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- MREO 61.43
- ITIC 52.87
- Support Level
- MREO $2.63
- ITIC $210.27
- Resistance Level
- MREO $2.85
- ITIC $218.93
- Average True Range (ATR)
- MREO 0.16
- ITIC 5.82
- MACD
- MREO -0.01
- ITIC 2.50
- Stochastic Oscillator
- MREO 79.41
- ITIC 85.37
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.